Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Express Scripts Holding Co    ESRX

Delayed Quote. Delayed  - 02/10 04:00:00 pm
67.11 USD   -0.07%
02/10DJCVS Gets Boost From Prescription-Drug Sales
02/09DJCVS Profit Grows on Higher Sales of Prescription Drugs -- 3rd Upd..
02/09DJCVS Profit Grows, But Forecast Soft
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201220132014201520162017
Sales93 858104 099100 887102 211103 895106 833
Operating income (EBITDA)5 3956 6646 8037 0697 3427 500
Operating profit (EBIT)5 1286 2956 4336 6456 8537 053
Pre-Tax Profit (EBT)2 1913 030----
Net income1 3131 8452 0082 5772 9603 175
P/E ratio30,731,232,118,715,313,4
EPS ( $ )1,762,252,643,594,394,99
Dividend per Share ( $ )------
Yield------
Reference price ( $ )5470.2484.6767.1167.1167.11
Announcement Date02/18/2013
09:01pm
02/20/2014
09:48pm
02/23/2015
09:01pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201220132014201520162017
Debt13 12111 95611 73512 94413 24712 359
Finance------
Operating income (EBITDA)5 3956 6646 8037 0697 3427 500
Leverage
(Debt/EBITDA)
2,43x1,79x1,73x1,83x1,80x1,65x
Capital Expenditure160423437320384406
Book Value Per Share (BVPS)28,6 $28,2 $27,6 $25,0 $24,0 $23,6 $
Cash Flow per Share6,36 $5,80 $5,99 $6,88 $8,32 $9,22 $
Announcement Date02/18/2013
09:01pm
02/20/2014
09:48pm
02/23/2015
09:01pm
---
Balance Sheet Analysis
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2015e 2016e
Capitalization 45 385 M$ -
Entreprise Value (EV) 58 329 M$ 58 632 M$
Valuation 2015e 2016e
P/E ratio (Price / EPS) 18,7x 15,3x
Capitalization / Revenue 0,44x 0,44x
EV / Revenue 0,57x 0,56x
EV / EBITDA 8,25x 7,99x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 2,68x 2,80x
Profitability 2015e 2016e
Operating Margin (EBIT / Sales) 6,50% 6,60%
operating Leverage (Delta EBIT / Delta Sales) 2,51x 1,91x
Net Margin (Net Profit / Revenue) 2,52% 2,85%
ROA (Net Profit / Asset) 7,21% 8,00%
ROE (Net Profit / Equities) 18,0% 22,8%
Rate of Dividend - -
Balance Sheet Analysis 2015e 2016e
CAPEX / Sales   0,31% 0,37%
Cash Flow / Sales 4,55% 5,42%
Capital Intensity (Assets / Sales) 0,35x 0,36x
Financial Leverage (Net Debt / EBITDA) 1,83x 1,80x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend